Article Per Year (5 Year)
p-Index From 2020 - 2025
0.983
P-Index
This Author published in this journals
All Journal Buletin Peternakan Jurnal Ilmu Ternak Veteriner Cosmogov: Jurnal Ilmu Pemerintahan El-Wasathiya: Jurnal Studi Agama Jurnal Scientia Jurnal Ekonomi Jurnal Multidisiplin Sahombu Ezra Science Bulletin
Ahmad Subhan
Unknown Affiliation
Religion Arts Humanities Civil Engineering, Building, Construction & Architecture Computer Science & IT Economics, Econometrics & Finance Education Environmental Science Law, Crime, Criminology & Criminal Justice Mathematics Social Sciences Veterinary Other

Published : 8 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Jurnal Ekonomi

 1 
Analysis Of Risk Factors For Acute Kidney Injury (AKI) With The Use Of Favipiravir And Remdesivir In Covid-19 Patients At Fatmawati Central General Hospital Nurlela Nurlela; Hesty Utami Ramadaniati; Yusi Anggriani; Ahmad Subhan
Jurnal Ekonomi Vol. 13 No. 02 (2024): Jurnal Ekonomi, Edition April - June 2024
Publisher : SEAN Institute

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

COVID-19 patients are very vulnerable to complications of Acute Kidney Injury (AKI), there are many factors causing complications one of which is kidney toxic therapy, antiviral therapy is considered potentially toxic to the kidneys because most of it is excreted through the kidneys. This study was conducted to examine the risk factor profile of AKI in COVID-19 patients taking antivirals Remdesivir and Favipiravir. This study is an observational study with a cross-sectional design at Fatmawati Hospital. The sampling method uses total sampling during the period August 2020-July 2021. The data used is medical record. Bivariate analysis uses Chi-square, and multivariate analysis uses logistic regression. a sample of 208 patients who met the inclusion criteria in the period August 2020-July 2021 in the COVID-19 isolation room of Fatmawati Hospital. 135 patients using Favipiravir, 37 identified as having an AKI event and 73 patients using Remdesivir, 19 were identified as having an AKI event. Multivariate analysis with logistic regression showed that male sex and severity of severe to critical severity significantly influenced the incidence of AKI. The use of Favipiravir and Remdesivir in COVID-19 patients is not a risk factor for AKI.
Co-Authors Arif Nugroho E.S Rohaeni Gugun Gunawan Hendrarso, Panji Hesty Utami Ramadaniati J.Hp Sidadolog Jafendi Hasoloan Purba Sidadolog Multi Albar, Yuli Hendra Mutia Rizky Septiani Nina Kurnia Nurlela Nurlela Suhroji Adha T Yuwanta Tri Yuwanta Yusi Anggriani